uniQure N.V. - Ordinary Shares (QURE): Price and Financial Metrics
QURE Price/Volume Stats
| Current price | $5.70 | 52-week high | $11.35 |
| Prev. close | $5.82 | 52-week low | $3.73 |
| Day low | $5.50 | Volume | 995,700 |
| Day high | $5.80 | Avg. volume | 1,391,742 |
| 50-day MA | $5.93 | Dividend yield | N/A |
| 200-day MA | $5.75 | Market Cap | 277.84M |
QURE Stock Price Chart Interactive Chart >
uniQure N.V. - Ordinary Shares (QURE) Company Bio
uniQure is a biopharmaceutical company, developing adeno-associated virus (AAV) based gene therapies through its technology platform for multiple therapeutic areas. The company was founded in 1998 and is based in Amsterdam, the Netherlands.
QURE Price Returns
| 1-mo | -14.29% |
| 3-mo | -7.92% |
| 6-mo | 19.75% |
| 1-year | -16.05% |
| 3-year | -80.22% |
| 5-year | -89.04% |
| YTD | -15.81% |
| 2023 | -70.14% |
| 2022 | 9.31% |
| 2021 | -42.60% |
| 2020 | -49.58% |
| 2019 | 148.65% |
Continue Researching QURE
Want to see what other sources are saying about uniQure NV's financials and stock price? Try the links below:uniQure NV (QURE) Stock Price | Nasdaq
uniQure NV (QURE) Stock Quote, History and News - Yahoo Finance
uniQure NV (QURE) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...